Balázs Tamás Németh

Balázs Tamás Németh

Auto-generated profile, based on publicly available information

Balázs Tamás Németh

Experimental Research Laboratory, Heart and Vascular Center, Semmelweis University, Budapest, Hungary

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2015 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
CMCsaba Mátyás
Csaba Mátyás
BNBalázs Tamás Németh
Balázs Tamás Németh
AOAttila Oláh
Attila Oláh
LHLászló Hidi
László Hidi
EBEde Birtalan
Ede Birtalan
TRTamás Radovits
Tamás Radovits
Diabetes mellitus (DM) leads to the development of diabetic cardiomyopathy, which is associated with altered nitric oxide (NO)—soluble guanylate cyclase (sGC)—cyclic guanosine monophosphate (cGMP) signalling. Cardioprotective effects of elevated intracellular cGMP-levels have been described in different heart diseases. In the current study we aimed at investigating the effects of pharmacological activation of sGC in diabetic cardiomyopathy. Type-1 DM was induced in rats by streptozotocin. Animals were treated either with the sGC activator cinaciguat (10 mg/kg/day) or with placebo orally for 8 weeks. Left ventricular (LV) pressure–volume (P–V) analysis was used to assess cardiac performance. Additionally, gene expression (qRT-PCR) and protein expression analysis (western blot) were performed. Cardiac structure, markers of fibrotic remodelling and DNA damage were examined by histology, immunohistochemistry and TUNEL assay, respectively. DM was associated with deteriorated cGMP signalling in the myocardium (elevated phosphodiesterase-5 expression, lower cGMP-level and impaired PKG activity). Cardiomyocyte hypertrophy, fibrotic remodelling and DNA fragmentation were present in DM that was associated with impaired LV contractility (preload recruitable stroke work (PRSW): 49.5 ± 3.3 vs. 83.0 ± 5.5 mmHg, P < 0.05) and diastolic function (time constant of LV pressure decay (Tau): 17.3 ± 0.8 vs. 10.3 ± 0.3 ms, P < 0.05). Cinaciguat treatment effectively prevented DM related molecular, histological alterations and significantly improved systolic (PRSW: 66.8 ± 3.6 mmHg) and diastolic (Tau: 14.9 ± 0.6 ms) function. Cinaciguat prevented structural, molecular alterations and improved cardiac performance of the diabetic heart. Pharmacological activation of sGC might represent a new therapy approach for diabetic cardiomyopathy.

16 January 2018 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
CMCsaba Mátyás
Csaba Mátyás
AKAttila Kovács
Attila Kovács
BNBalázs Tamás Németh
Balázs Tamás Németh
AOAttila Oláh
Attila Oláh
SBSzilveszter Braun
Szilveszter Braun
TRTamás Radovits
Tamás Radovits
Measurement of systolic and diastolic function in animal models is challenging by conventional non-invasive methods. Therefore, we aimed at comparing speckle-tracking echocardiography (STE)-derived parameters to the indices of left ventricular (LV) pressure–volume (PV) analysis to detect cardiac dysfunction in rat models of type-1 (T1DM) and type-2 (T2DM) diabetes mellitus. Rat models of T1DM (induced by 60 mg/kg streptozotocin, n = 8) and T2DM (32-week-old Zucker Diabetic Fatty rats, n = 7) and corresponding control animals (n = 5 and n = 8, respectively) were compared. Echocardiography and LV PV analysis were performed. LV short-axis recordings were used for STE analysis. Global circumferential strain, peak strain rate values in systole (SrS), isovolumic relaxation (SrIVR) and early diastole (SrE) were measured. LV contractility, active relaxation and stiffness were measured by PV analysis. In T1DM, contractility and active relaxation were deteriorated to a greater extent compared to T2DM. In contrast, diastolic stiffness was impaired in T2DM. Correspondingly, STE described more severe systolic dysfunction in T1DM. Among diastolic STE parameters, SrIVR was more decreased in T1DM, however, SrE was more reduced in T2DM. In T1DM, SrS correlated with contractility, SrIVR with active relaxation, while in T2DM SrE was related to cardiac stiffness, cardiomyocyte diameter and fibrosis. Strain and strain rate parameters can be valuable and feasible measures to describe the dynamic changes in contractility, active relaxation and LV stiffness in animal models of T1DM and T2DM. STE corresponds to PV analysis and also correlates with markers of histological myocardial remodeling.

22 May 2014 in Cardiologia Croatica
Verified
Journal Article
Closed access
BNBalazs Tamas Nemeth
Balazs Tamas Nemeth
CMCsaba Matyas
Csaba Matyas
AOAttila Oláh
Attila Oláh
LHLaszlo Hidi
Laszlo Hidi
MRMihály Ruppert
Mihály Ruppert
TRTamás Radovits
Tamás Radovits

1 January 2018 in Cardiologia Hungarica
Verified
Journal Article
Closed access
AOAttila Oláh
Attila Oláh
ASAlex Ali Sayour
Alex Ali Sayour
BNBalázs Tamás Németh
Balázs Tamás Németh
CMCsaba Mátyás
Csaba Mátyás
LHLászló Hidi
László Hidi
TRTamás Radovits
Tamás Radovits

1 January 2018 in Cardiologia Hungarica
Verified
Journal Article
Closed access
MRMihály Ruppert
Mihály Ruppert
BBBálint András Barta
Bálint András Barta
SKSevil Korkmaz-Icöz
Sevil Korkmaz-Icöz
SLShiliang Li
Shiliang Li
AOAttila Oláh
Attila Oláh
GSGábor Szabó
Gábor Szabó